InvestorsHub Logo
Followers 210
Posts 32172
Boards Moderated 1
Alias Born 06/30/2009

Re: changes_iv post# 114563

Saturday, 08/22/2015 4:34:47 PM

Saturday, August 22, 2015 4:34:47 PM

Post# of 146240
"The study was conducted by KARD Scientific, Inc. Dr. Krishna Menon, President of KARD and consulting Regulatory Officer for NanoViricides, Inc., has advised the Company that some of the orally administered drug candidates provided by NanoViricides showed efficacy in combatting highly lethal influenza H1N1 infection in mice."

Uncle Kirishna says it works great!

“I have had a wonderful time but this wasn't it.”
..........Groucho

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News